🏥Bio Business Status

  1. New Drug Development

    • Gene Therapy: With the expansion of clinical trials for gene therapy, the value of companies manufacturing viruses in GMP facilities is increasing. Many gene therapies are entering the final stages of clinical trials, leading to an expansion of facilities producing virus vectors and large-scale cell therapies.

    • Organ-on-a-Chip Tech: Over 25 companies hold their own data and share databases in non-competitive fields. Expected to be mainly utilized in toxicology, it is under discussion with the FDA. Although issues such as standardization and quality control need to be addressed, gradual progress is anticipated.

    • Artificial Intelligence (AI): Most global bio companies anticipate that artificial intelligence will be helpful in understanding diseases and analyzing image data in the early stages of drug development, particularly in cancer treatment and other disease areas.

    • Others: Technologies such as Microbiome, Cell Line, Antibody Fc Engineering, and Plant Protein Expression are also gaining attention.

  2. Immunity Enhancement

  • With the global spread of COVID-19, there has been increased attention on immunity enhancement technologies. Patent applications are increasing in fields such as biological processing, cultivation and processing technology, extraction and refining technology, and physical and chemical processing technology. The ratio of applications from companies is highest at 42%, indicating active industrial-academic collaboration, reflecting the nature of technology being developed and commercialized. Companies, educational institutions, and research institutions will continue to steadily develop technologies related to enhancing immunity.

  1. Smart Telemedicine

  • Smart telemedicine is gaining attention due to the prevention of infections within medical institutions and hospital closures caused by COVID-19. Real-time consultations via video conferencing and large-scale digital image transmission contribute to cost reduction and improved accessibility of medical services.

  1. Medical Robot

  • Medical robot technology requires precision and high complexity, with various platforms such as surgical robots, microsurgery robots, and artificial micro-cluster robots under development. Research is being conducted in various application areas in the United States, Germany, Japan, China, and other countries.

PreviousEffectNextMarketability

Last updated